食品伙伴網(wǎng)訊  據(jù)澳新食品標(biāo)準(zhǔn)局消息，9月25日澳新食品標(biāo)準(zhǔn)局發(fā)布通知公告23-15，就使用兩種沙門氏菌噬菌體制劑（S16、FO1a）作為加工助劑來(lái)降低沙門氏菌的污染風(fēng)險(xiǎn)開(kāi)始征求意見(jiàn)。征求意見(jiàn)的截止日期為2015年11月6日。

    2015年3月13日澳新局收到Micreos B.V. 公司申請(qǐng)，要求將兩種沙門氏菌噬菌體制劑用于防控肉禽產(chǎn)品宰后加工過(guò)程中的沙門氏菌。

    部分原文報(bào)道如下：

    FSANZ received an application （Application A1111） from Micreos B.V. on 13 March 2015, to permit a Salmonella phage preparation （S16 and FO1a）， tradename Salmonelex TM,（subsequently called Salmonella phage in this report） for use as a processing aid aimed at controlling Salmonella spp. during post-slaughter processing of fresh meat and poultry  products.

    Salmonella is one of the most commonly reported causes of foodborne illness, with fresh raw meat and poultry often implicated as a source of infection. Fresh raw meat and poultry can  be contaminated with Salmonella which can cause illness if meat is consumed undercooked or if cross contamination occurs during handling and preparation.

    原文鏈接：http://www.foodstandards.gov.au/code/applications/documents/A1111-CFS-SD1.pdf